CSCI
COSCIENS Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · CA
$2.72
+0.00%Sep 16, 2026, 23:00 UTC
COSCIENS Biopharma Inc. closed the second tranche of its non-brokered private placement of 15% unsecured convertible debentures, issuing an additional US$4,375,000 in principal amount for a cumulative US$10,706,250.
Source:Aug 11, 2026, 21:55 UTC
COSCIENS Biopharma Inc. reported a net loss of $202,000 for its second quarter, with revenue of $3.1 million.
Source: